# Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis

> **NCT07718529** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 224 (estimated)

## Conditions studied

- Ulcerative Colitis in Remission

## Interventions

- **DRUG:** treatment withdrawal

## Key facts

- **NCT ID:** NCT07718529
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2030-01
- **Final completion:** 2031-01
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07718529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07718529, "Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07718529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*